- Home
- JSPRW vs NXRT Comparison
JSPRW vs NXRT Comparison
Compare JSPRW & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPRW
- NXRT
- Stock Information
- Founded
- JSPRW N/A
- NXRT 2014
- Country
- JSPRW United States
- NXRT United States
- Employees
- JSPRW 45
- NXRT N/A
- Industry
- JSPRW Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- JSPRW Health Care
- NXRT Real Estate
- Exchange
- JSPRW Nasdaq
- NXRT Nasdaq
- Market Cap
- JSPRW N/A
- NXRT N/A
- IPO Year
- JSPRW 2020
- NXRT N/A
- Fundamental
- Price
- JSPRW $0.19
- NXRT $45.54
- Analyst Decision
- JSPRW
- NXRT Buy
- Analyst Count
- JSPRW 0
- NXRT 5
- Target Price
- JSPRW N/A
- NXRT $49.00
- AVG Volume (30 Days)
- JSPRW N/A
- NXRT 126.5K
- Earning Date
- JSPRW N/A
- NXRT 10-29-2024
- Dividend Yield
- JSPRW N/A
- NXRT 4.48%
- EPS Growth
- JSPRW N/A
- NXRT 54.64
- EPS
- JSPRW N/A
- NXRT 1.77
- Revenue
- JSPRW N/A
- NXRT $264,974,000.00
- Revenue This Year
- JSPRW N/A
- NXRT N/A
- Revenue Next Year
- JSPRW N/A
- NXRT $0.52
- P/E Ratio
- JSPRW N/A
- NXRT $25.73
- Revenue Growth
- JSPRW N/A
- NXRT N/A
- 52 Week Low
- JSPRW N/A
- NXRT $28.20
- 52 Week High
- JSPRW N/A
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- JSPRW N/A
- NXRT 58.31
- Support Level
- JSPRW N/A
- NXRT $45.75
- Resistance Level
- JSPRW N/A
- NXRT $46.91
- Average True Range (ATR)
- JSPRW 0.00
- NXRT 1.24
- MACD
- JSPRW 0.00
- NXRT 0.33
- Stochastic Oscillator
- JSPRW 0.00
- NXRT 78.87
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.